Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00669630 · ClinicalTrials.gov registry record · NA

The GoodNEWS Lifestyle Enhancement Program

A NA study of Obesity and Hypertension, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
392
Enrollment target
1
Study location

NCT00669630: Completed NA study of Obesity and Hypertension, sponsored by University of Texas Southwestern Medical Center.

NCT00669630 is a NA study of Obesity and Hypertension that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 392 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00669630, a NA study of Obesity and Hypertension, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
392 participants
Enrollment target
1
Study location

Study Summary

This study will train Lay Health Promoters (LHPs) from African-American churches to administer healthy living lessons and activities to their congregations in order to improve overall health and address cardiovascular disease. The primary hypothesis is that LHP training combined with a well supported maintenance strategy will be more effective than LHP training alone in reducing risk factors for cardiovascular disease.

Interventions

  • BEHAVIORAL Lay Health Promoter (LHP) with maintenance

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 392 participants
Start Date 2008-09
Est. Completion 2012-06
Phase NA

What the finished NCT00669630 record still lists

NCT00669630 is an interventional study that assigns participants to a tested intervention. The registered 392 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (52% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Lay Health Promoter (LHP) with maintenance is the first listed.

NCT00669630 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00669630 about?

NCT00669630 is a clinical study titled "The GoodNEWS Lifestyle Enhancement Program". This study will train Lay Health Promoters (LHPs) from African-American churches to administer healthy living lessons and activities to their congregations in order to improve overall health and address cardiovascular disease. The primary hypothesis is that LHP training combined with a well supporte...

What is the current status of trial NCT00669630?

This trial is currently completed. It is a NA study. The enrollment target is 392 participants. The study started on 2008-09. Estimated completion is 2012-06.

What conditions does trial NCT00669630 study?

This clinical trial studies the following conditions: Obesity, Hypertension, Diabetes, Cardiovascular Disease.

What interventions are being tested in trial NCT00669630?

The interventions under investigation include: Lay Health Promoter (LHP) with maintenance (BEHAVIORAL).

Who is sponsoring clinical trial NCT00669630?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00669630 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00669630's enrollment target sits among peer trials

392 174th of 1053 higher than 879 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06397703 · 392 participants · Phase 2

    ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer

  • NCT06625775 · 392 participants · Phase 1

    Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • NCT07220967 · 392 participants · Phase 4

    A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

  • NCT07290036 · 392 participants · Phase 1

    A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00669630, the US trial registry maintained by the National Library of Medicine. NCT00669630 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.